Linda Duska, MD
Enriched profileProfessor of Obstetrics and Gynecology; Associate Dean for Clinical Research, UVA School of Medicine · University of Virginia Health System
Linda Duska is Professor of Obstetrics and Gynecology; Associate Dean for Clinical Research, UVA School of Medicine at University of Virginia Health System. OpenAlex indexes 449 publications with 8,621 citations (h-index 45); ClinicalTrials.gov lists 18 registered studies with this person as an investigator.
Data verified 18 Oct 2026
Overview
Updated 18 Oct 2026
Linda Duska, MD, is Professor of Obstetrics and Gynecology at University of Virginia Health System. The public record shows 449 publications with 8,621 citations (h-index 45), centered on Endometrial and Cervical Cancer Treatments, Ovarian cancer diagnosis and treatment, Cervical Cancer and HPV Research. It also documents an investigator role on 18 registered clinical trials, industry payments reported by 10 companies, 1 NIH-funded awards (2024–2026).
- Most recent indexed publication: 2025 · Cancer
- Top research focus: Endometrial and Cervical Cancer Treatments
- 18 registered trials on ClinicalTrials.gov
- Open Payments reporting from 10 companies
Generated from the cited public record · current as of 18 Oct 2026. Every fact links its source below.
Indications focus
from trials led + research topicsResearch focus
OpenAlex concept fingerprintDrugs & molecules
across trials, industry payments and publicationsWorks with
trial sponsors and companies reporting paymentsScholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex, matched via ORCID; 14 in PubMed.
Total citations across indexed works.
Hirsch index (OpenAlex). i10-index 147.
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
Telephone
Practice address and telephone from the federal NPPES registry.
Sign in to view contact details →Clinical trials
Updated 18 Oct 2026
Listed as an investigator on 18 registered studies on ClinicalTrials.gov. The most recent:
- Progestins for the Treatment of Endometrial Cancer or Precancers of the Uterus Before Surgery, The Pro-Window Trial
Sponsor: New Mexico Cancer Research Alliance
- A Study With NKT3964 for Adults With Advanced/Metastatic Solid Tumors
Sponsor: NiKang Therapeutics, Inc.
Industry payments
Updated 18 Oct 2026
10 companies reported payments to CMS in program years 2021–2025. These are public disclosures, not judgments. The latest:
- Merck Sharp & Dohme LLCProgram year20255 payments$19,054openpaymentsdata.cms.gov ↗
- Corcept TherapeuticsProgram year20257 payments
- Karyopharm Therapeutics Inc.Program year20252 payments
Medicare prescribing footprint (2024)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Nervous system
31.1%Phenothiazine31.1%Prochlorperazine Maleate100%Part D≥16 patientsMetabolism & gastrointestinal
25.2%Serotonin-3 Receptor Antagonist25.2%Ondansetron Hcl100%Part D≥19 patientsGenitourinary & hormones
22.3%Progestin22.3%Megestrol Acetate100%Part D<11 patients
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
NIH funding
Updated 18 Oct 2026
1 NIH research award on record, funded 2024–2026 per NIH RePORTER. The latest:
- Enhancing accrual across gynecologic and solid tumor trials
University of Virginia
FY2026$135,573R50CA285360 - Enhancing accrual across gynecologic and solid tumor trials
University of Virginia
FY2025$135,573R50CA285360 - Enhancing accrual and diversity across gynecologic and solid tumor trials
University of Virginia
FY2024$135,573R50CA285360
Congress activity
Updated 18 Oct 2026
60 congress contributions (2005–2025) across AACR, ASCO, ESMO per OpenAlex. The most recent:
- Molecular heterogeneity in dMMR/MSI-H endometrial cancer in the US.
ASCO Annual Meeting
ASCO2025Co-author
Published abstracts are attributed via the same ORCID-disambiguated authorship as publications, so each is DOI-verified. Podium roles (invited talks, session chairs) and oral/poster type are added as program data is confirmed.
Publications
Updated 18 Oct 2026
Their five most recent publications, matched to their ORCID record and linked to PubMed.
- Randomized Phase II Study of Bevacizumab with Weekly Anetumab Ravtansine or Weekly Paclitaxel in Platinum-Resistant/Refractory High-Grade Ovarian Cancer (NCI Trial).
Clinical cancer research
Clinical Trial2025 - Cediranib and Olaparib Combination Compared With Cediranib or Olaparib Alone, or Chemotherapy in Platinum-Resistant or Primary Platinum-Refractory Ovarian Cancer: NRG-GY005.
Journal of clinical oncology
Clinical Trial2024 - Comprehensive Target Engagement by the EZH2 Inhibitor Tulmimetostat Allows for Targeting of ARID1A Mutant Cancers.
Cancer research
Clinical Trial2024
Most-cited works
by citation count (OpenAlex)Network
Updated 18 Oct 2026
The people this person publishes with most, by number of co-authored papers. Names link to their own profile when we have one.
Online presence
Updated 18 Oct 2026
This person's own public accounts first, then places where others mention them. Two different things, listed separately.
Owned accounts
public accounts run by this person- Other
uvahealth.com/providers/Linda-Duska-1447241807
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →uvahealth.com ↗ - Doximity
doximity.com/pub/linda-duska-md
provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →doximity.com ↗
We list an account only when the public record ties it to this person. verified means we've confirmed the match in more than one place; provisional means it looks right but we're still confirming.
Background & recognition
Updated 18 Oct 2026
Credentials, appointments and honors, newest first, each linked to the public source it came from.
Education
degrees and training on record- verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →uvahealth.com ↗
- provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →uvahealth.com ↗
Editorial & leadership roles
journal and society appointments- Vice Chair for Research
Department of Obstetrics and Gynecology, University of Virginia
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →uvahealth.com ↗ - Director
Gynecologic Oncology Fellowship Program, University of Virginia
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →uvahealth.com ↗ - Editor-in-Chief
ASCO Connection
provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →connection.asco.org ↗ - Board Member
Society of Gynecologic Oncology
provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →newswise.com ↗ - Secretary-Treasurer
Society of Gynecologic Oncology
provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →newswise.com ↗ - Board Member
Foundation for Women's Cancer
provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →newswise.com ↗
Awards & honors
honors on the public record- verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →med.virginia.edu ↗
- verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →uvahealth.com ↗
- verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →uvahealth.com ↗
- provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →ascopost.com ↗
- provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →targetedonc.com ↗
- provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →targetedonc.com ↗
Secondary affiliations
appointments beyond the home institution- verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →uvahealth.com ↗
- verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →uvahealth.com ↗
Every item links to where we found it. verified means we've confirmed it in more than one place; provisional means we found it and are still confirming.
Similar KOLs
Other experts from the same institution or the same specialty.
Benjamin Purow, MD
University of Virginia Health System
Kenneth Bilchick, MD
University of Virginia Health System
Mark Stoler, MD
University of Virginia Health System
Irving Kron, MD
University of Virginia Health System
Baha Sibai, MD
McGovern Medical School at UTHealth Houston
Robert Coleman, MD
Vaniam Group
Kathleen Moore, MD
University of Nebraska Medical Center
Bradley Monk, MD
Florida Cancer Specialists & Research Institute